HL PHARMA has been awarded Section 19A(1) approval by the Therapeutic Goods Administration to supply amiloride 5mg tablets.
The approval aims to help address short supply/unavailability of Kaluril (amiloride) 5mg tablets.
The above article was sent to subscribers in Pharmacy Daily's issue from 04 Sep 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Sep 18